Thai healthcare system faces a critical inflection point: aging population and rising medical costs are straining government finances, expected to push 100,000+ million baht in healthcare burden to private sector by 2025. Private health insurance penetration is only 6.4% with 8% annual growth, offering substantial upside. KKPS upgrades hospital stocks to Overweight with "Buy" ratings on BH, BDMS, PR9, BCH, and CHG, citing Q3 recovery trajectory, attractive valuations (P/E 19x vs regional 30x), and 4-5% dividend yields. Foreign patient revenue rebounding as geopolitical impacts ease.